Better outcome for rheumatoid arthritis patients given intensive outpatient treatment (p 263)July 14, 2004Results of a UK study in this week's issue of THE LANCET suggest that intensive monthly outpatient treatment with antirheumatic drugs and steroid injections can substantially improve patients' symptoms of rheumatoid arthritis compared with standard three-month outpatient treatment. Duncan Porter (Gartnavel General Hospital, Glasgow, UK) and colleagues investigated whether a more intensive approach-monthly assessment of patients' disease activity score (DAS) to guide treatment with oral antirheumatic drugs and steroid injections-could be more effective in improving symptoms than standard three-monthly assessment without a DAS calculation to guide treatment. The investigators randomized 111 people with rheumatoid arthritis to either intensive management or routine care. The study's main outcome measure was to compare the proportion of patients in each group achieving a good response to treatment-defined as a DAS below 2"¢4 and a fall in this score from baseline by more than 1"¢2 points. Comparisons between patients in the two groups were made after 18 months. 82% of patients given intensive therapy achieved a good response to treatment compared with 44% in the standard treatment group. Furthermore, 65% of patients in the intensive group were in remission at the end of the study compared with only 16% of patients in the standard group. Intensive treatment was no more costly than standard treatment. Dr Porter comments: "The results of this study have considerable implications for the management of people with rheumatoid arthritis. Despite initial concerns, cost did not differ between intensive management of patients and routine treatment. Whether the improvement in patients' outcomes will translate into longer-term savings, such as a reduction in work disability, the need for joint-replacement surgery, or the need for institutional care, remains to be seen. More importantly, our results show that a strategy of optimising current techniques and treatment regimens can deliver substantial patients' benefits within a cost-neutral framework." | |||||||||||||||||||||
|
Related Arthritis Current Events and Arthritis News Articles Groundbreaking, inexpensive, pocket-sized ultrasound device can help treat cancer, relieve arthritis A prototype of a therapeutic ultrasound device, developed by a Cornell graduate student, fits in the palm of a hand, is battery-powered and packs enough punch to stabilize a gunshot wound or deliver drugs to brain cancer patients. Mayo Clinic study finds increased risk of pneumococcal disease in asthma patients Mayo Clinic research shows adults with asthma are at increased risk of serious pneumococcal disease caused by Streptococcus pneumoniae, the most common bacteria causing middle ear infections and community acquired pneumonia. Potential autoimmunity-inducing cells found in healthy adults It's not just patients with autoimmune diseases like lupus and rheumatoid arthritis (RA) that have self-attacking immune cells-healthy people have them too, according to a new report in the Journal of Experimental Medicine. Patients with severe psoriasis need evaluation of heart disease risk According to new recommendations in the December 10 issue of The American Journal of Cardiology (AJC), published by Elsevier, new research is called for and patients with severe forms of the skin disease psoriasis should receive evaluation and possible treatment to reduce their risk of coronary artery disease (CAD). Vitamin D deficiency in infants and nursing mothers carries long-term disease risks Once believed to be important only for bone health, vitamin D is now seen as having a critical function in maintaining the immune system throughout life. Mathematical models of adaptive immunity More than five million people die every year from infectious diseases, despite the availability of numerous antibiotics and vaccines. Gene therapy effective treatment against gum disease Scientists at the University of Michigan have shown that gene therapy can be used to successfully stop the development of periodontal disease, the leading cause of tooth loss in adults. Pine bark reduces inflammatory marker CRP in osteoarthritis Osteoarthritis (OA), a type of arthritis caused by the breakdown and loss of cartilage, affects more than 20 million Americans. Novel bioreactor enhances interleukin-12 production in genetically-modified tobacco plants Interleukin-12 is a naturally occurring protein essential for the proper functioning of the human immune system. Researchers identify cell group key to Lyme disease arthritis A research team led by the La Jolla Institute for Allergy & Immunology and Albany Medical College has illuminated the important role of natural killer (NK) T cells in Lyme disease, demonstrating that the once little understood white blood cells are central to clearing the bacterial infection and reducing the intensity and duration of arthritis associated with Lyme disease. More Arthritis Current Events and Arthritis News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||